N
Novoprotein Scientific Inc
SSE:688137
Novoprotein Scientific Inc
SSE:688137
Price:
50.47
CNY
1.43%
Market Closed
Market Cap:
¥2.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Novoprotein Scientific Inc
SSE:688137
|
CN |
|
Wing On Company International Ltd
HKEX:289
|
HK |
Income Statement
Earnings Waterfall
Novoprotein Scientific Inc
Novoprotein Scientific Inc
Income Statement
Novoprotein Scientific Inc
Novoprotein Scientific Inc
Currency: CNY
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
2
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
3
|
0
|
0
|
|
| Revenue |
377
N/A
|
277
-27%
|
265
-4%
|
308
+16%
|
173
-44%
|
163
-6%
|
153
-6%
|
136
-11%
|
138
+1%
|
135
-3%
|
128
-5%
|
135
+6%
|
140
+4%
|
147
+5%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(46)
|
(32)
|
(54)
|
(45)
|
(31)
|
(36)
|
(71)
|
(41)
|
(49)
|
(52)
|
(72)
|
(54)
|
(53)
|
(56)
|
|
| Gross Profit |
331
N/A
|
244
-26%
|
210
-14%
|
262
+25%
|
142
-46%
|
127
-11%
|
82
-35%
|
96
+16%
|
89
-7%
|
82
-8%
|
56
-32%
|
81
+45%
|
87
+7%
|
91
+5%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(134)
|
(114)
|
(117)
|
(168)
|
(143)
|
(160)
|
(121)
|
(150)
|
(151)
|
(152)
|
(137)
|
(179)
|
(187)
|
(189)
|
|
| Selling, General & Administrative |
(86)
|
(70)
|
(81)
|
(107)
|
(87)
|
(98)
|
(81)
|
(88)
|
(95)
|
(97)
|
(92)
|
(103)
|
(100)
|
(99)
|
|
| Research & Development |
(40)
|
(38)
|
(38)
|
(52)
|
(48)
|
(50)
|
(42)
|
(45)
|
(42)
|
(41)
|
(45)
|
(52)
|
(54)
|
(56)
|
|
| Depreciation & Amortization |
0
|
0
|
(9)
|
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(8)
|
(6)
|
12
|
(10)
|
(8)
|
(12)
|
12
|
(17)
|
(14)
|
(14)
|
17
|
(24)
|
(33)
|
(33)
|
|
| Operating Income |
196
N/A
|
130
-34%
|
93
-28%
|
94
+0%
|
(2)
N/A
|
(34)
-1 944%
|
(38)
-14%
|
(54)
-41%
|
(62)
-14%
|
(70)
-13%
|
(82)
-17%
|
(98)
-20%
|
(100)
-2%
|
(97)
+3%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
0
|
0
|
11
|
21
|
34
|
44
|
45
|
46
|
41
|
37
|
37
|
35
|
34
|
32
|
|
| Non-Reccuring Items |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
0
|
1
|
1
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
2
|
2
|
1
|
0
|
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
198
N/A
|
132
-33%
|
106
-20%
|
116
+9%
|
31
-73%
|
10
-68%
|
6
-38%
|
(9)
N/A
|
(21)
-134%
|
(33)
-56%
|
(54)
-63%
|
(65)
-19%
|
(67)
-3%
|
(65)
+2%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
(31)
|
(21)
|
(15)
|
(14)
|
0
|
6
|
7
|
8
|
13
|
12
|
(0)
|
1
|
(3)
|
0
|
|
| Income from Continuing Operations |
167
|
111
|
91
|
102
|
31
|
16
|
13
|
(1)
|
(8)
|
(21)
|
(54)
|
(64)
|
(70)
|
(65)
|
|
| Net Income (Common) |
167
N/A
|
111
-33%
|
91
-18%
|
102
+12%
|
31
-69%
|
16
-49%
|
13
-21%
|
(1)
N/A
|
(8)
-808%
|
(21)
-153%
|
(54)
-156%
|
(64)
-17%
|
(70)
-10%
|
(65)
+7%
|
|
| EPS (Diluted) |
2.38
N/A
|
1.59
-33%
|
1.29
-19%
|
1.45
+12%
|
0.45
-69%
|
0.23
-49%
|
0.18
-22%
|
-0.01
N/A
|
-0.12
-1 100%
|
-0.3
-150%
|
-0.78
-160%
|
-0.91
-17%
|
-1
-10%
|
-0.89
+11%
|
|
Switch to:
Switch to:
See Also
Discover More
